Cargando…
Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy
Results from randomized clinical trials over the last several years have finally begun to demonstrate the potential of oncolytic viral therapies to treat a variety of cancers. One reason for these successes has been the realization that this platform is most effective when considered primarily as an...
Autores principales: | Sampath, Padma, Thorne, Steve H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918382/ https://www.ncbi.nlm.nih.gov/pubmed/27512672 http://dx.doi.org/10.2147/OV.S54738 |
Ejemplares similares
-
Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012) -
Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017) -
Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015) -
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016) -
Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016)